Phase 2 Alopecia Areata Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with severe Alopecia Areata (a condition causing significant hair loss on the scalp)
- Your hair loss covers between 50% and 90% of your scalp, as measured by a standard hair loss scoring tool
- Your current episode of severe hair loss has been going on for at least 6 months but no longer than 4 years
- In your doctor's opinion, your hair has not significantly grown back on its own in at least the past 6 months
- You are willing to avoid using any hair loss treatments during the study
Who may not be able to join:
- Your hair loss is mainly the "diffuse" type, which means hair is shedding thinly and widely across the scalp rather than in patches
- You are currently experiencing another type of hair loss condition
- You have an unstable ongoing health condition that requires frequent hospital stays or regular use of medications that suppress the immune system (confirm with trial site)
- You have previously taken JAK inhibitor medications by mouth (a specific type of drug used to treat certain immune conditions)
- You have had a major surgery in the past 8 weeks, or you expect to need major surgery during the study
- You have a history of, or currently have, serious or unstable conditions affecting the heart, lungs, liver, digestive system, hormones, blood, brain, or mental health
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST), Eli Lilly and Company
Phone: 1-317-615-4559
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage of Participants Achieving an Absolute Severity of Alopecia Tool (SALT) Less than or Equal to (≤) 20
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.